-
Gilead appoints current Roche Pharmaceuticals CEO as new CEO and chairman
pharmaceutical-technology
December 11, 2018
The board of directors at Gilead Sciences has announced it has chosen Daniel O’Day, the current CEO of Roche Pharmaceuticals and member of the Roche Group’s corporate executive committee.....
-
MedPharm Appoints President & CEO
contractpharma
November 30, 2018
Mr. Ciolfi is charged with driving MedPharm’s growth further downstream into commercial manfacturing and opening up additional markets based on the company’s unique performance modelling, formulation development
-
CEO of MHRA set to leave agency in wake of Brexit
fiercebiotech
November 25, 2018
The of the Medicines and Healthcare products Regulatory Agency is set to leave the agency in 10 months. Ian Hudson’s decision means the agency faces the prospect of changing leaders while dealing with the fallout from Brexit.
-
Working through CEO swap, Pfizer plots job cuts in drive for 'simpler' structure
fiercepharma
October 19, 2018
A week after Pfizer unveiled a reshuffled executive team that'll report to incoming CEO Albert Bourla, the company said it's restructuring to simplify management and boost efficiency. And this latest move means job ...
-
Pfizer Names New CEO
contractpharma
October 08, 2018
Albert Bourla to succeed Ian Read
-
Georgia Bio Appoints Acting President and CEO
americanpharmaceuticalreview
September 27, 2018
Georgia Bio announced Maria Thacker Goethe has assumed the role of Acting President and CEO for the trade association and the Georgia BioEd Institute. She will also remain in her capacity as Executive Director for the Georgia Global Health Alliance.
-
Congrats, Ken Frazier: Merck's board scraps mandatory retirement to keep CEO at his post
fiercepharma
September 27, 2018
Happy early birthday, Kenneth Frazier.
-
Third Rock’s Rheos poaches Sanjay Keswani from Roche
fiercebiotech
September 07, 2018
Third Rock Ventures’ Rheos Medicines has named former Roche SVP Sanjay Keswani, M.D., as CEO.
-
Roche's CEO of the diagnostic division to step down
biospectrumasia
August 30, 2018
Michael Heuer, currently Region Head Europe, Middle East, Africa, and Latin America for Roche Diagnostics will assume the ad interim leadership of Roche’s Diagnostics Division and become a member of the Corporate Executive Committee
-
Novartis appoints new CEO for controversial Korean unit
biospectrumasia
August 24, 2018
Previously, the Korean Ministry of Health and Welfare fined Novartis ~$50M and suspended reimbursement of Exelon and Zometa for three months.